Hygeia Healthcare, a Chinese oncology healthcare group backed by Warburg Pincus, is planning to float shares on the Hong Kong Stock Exchange (HKEX) as the city board sees the appeal from healthcare and biotech companies for fund raising “rather strengthened” during the pandemic period.
End the Year with a Deal You Can’t Miss!
Subscribe now and save 40% on our premium subscription.
Enjoy unlimited access for a full year at just $199 (usual price $339).
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Offer valid for a limited time – don’t wait to unlock the insights that drive deal-making in Asia!
Subscribe nowAlready a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
